Impact of minimal residual disease prior to conditioning and chimerism after BMT in childhood acute lymphoblastic leukaemia.

被引：0
|
作者：
Hancock, J
Goulden, N
Oakhill, A
Ferris, V
Moppett, J
Burke, A
Garland, R
Groves, S
Cornish, J
Pamphilon, D
Steward, C
机构：
[1] Univ Bristol, Bristol BS8 1TH, Avon, England
[2] Royal Hosp Sick Children, Bristol BS2 8BJ, Avon, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2818
引用
收藏
页码：673A / 673A
页数：1
相关论文
共 50 条
  • [31] Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
    Coustan-Smith, E
    Behm, FG
    Sanchez, J
    Boyett, JM
    Hancock, ML
    Raimondi, SC
    Rubnitz, JE
    Rivera, GK
    Sandlund, JT
    Pui, CH
    Campana, D
    LANCET, 1998, 351 (9102): : 550 - 554
  • [32] Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia
    Nyvold, C
    Madsen, HO
    Ryder, LP
    Seyfarth, J
    Engel, CA
    Svejgaard, A
    Wesenberg, F
    Schmiegelow, K
    JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 233 (1-2) : 107 - 118
  • [33] Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia
    Foroni, L
    Hoffbrand, AV
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (01) : 71 - 90
  • [34] Prediction of relapse following unrelated BMT for childhood acute lymphoblastic leukaemia by serial analysis of early chimerism.
    Hancock, J
    Burgess, M
    Goulden, N
    Ferris, V
    Steward, C
    Potter, M
    Oakhill, A
    BLOOD, 1996, 88 (10) : 1060 - 1060
  • [35] Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
    C Lutz
    P S Woll
    G Hall
    A Castor
    H Dreau
    G Cazzaniga
    J Zuna
    C Jensen
    S A Clark
    A Biondi
    C Mitchell
    H Ferry
    A Schuh
    V Buckle
    S-E W Jacobsen
    T Enver
    Leukemia, 2013, 27 : 1204 - 1207
  • [36] Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
    Lutz, C.
    Woll, P. S.
    Hall, G.
    Castor, A.
    Dreau, H.
    Cazzaniga, G.
    Zuna, J.
    Jensen, C.
    Clark, S. A.
    Biondi, A.
    Mitchell, C.
    Ferry, H.
    Schuh, A.
    Buckle, V.
    Jacobsen, S-E W.
    Enver, T.
    LEUKEMIA, 2013, 27 (05) : 1204 - 1207
  • [37] Minimal residual disease monitoring in childhood acute lymphoblastic leukemia
    Campana, Dario
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (04) : 313 - 318
  • [38] MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    CARR, T
    STEVENS, RF
    LANCET, 1994, 343 (8891): : 190 - 190
  • [39] Childhood Acute Lymphoblastic Leukemia: Detection of Minimal Residual Disease after Allogeneic Transplantation
    Boldeanu, Florina M.
    Gruia, Alexandra T.
    Ordodi, Valentin L.
    Serban, Margit
    Bader, Peter
    Kreyenberg, Hermann
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2012, 20 (03): : 59 - 67
  • [40] Detection of minimal residual disease in childhood acute lymphoblastic leukemia after termination of therapy
    Wu, NH
    Lu, SG
    Zhu, P
    Peng, YY
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1996, 13 (03) : 257 - 263
12345